BD’s high-throughput molecular combination test for COVID-19 and Influenza A/B is CE / IVD marked
BD (Becton, Dickinson and Company) says their new high-throughput molecular diagnostic combination test for SARS-CoV-2 and Influenza A/B, is the second test available for the BD COR PX/MX System to have been CE marked to the IVD directive 98/79/EC.